Videos

The U.S. healthcare system is facing a deepening workforce shortage driven by policy constraints, limited training capacity and immigration barriers—issues that could significantly worsen in the coming years without reforms, according to Anders Gilberg, senior vice president, government affairs at Medical Group Management Association (MGMA), in the above video interview. #MGMA #IMMIGRATION

MGMA supports bipartisan effort to eliminate $100K visa fee for healthcare workers

MGMA says Trump’s immigration policy combined with Congress’s unwillingness to fund additional medical residency positions is a primary driver accelerating the growing U.S. healthcare staffing shortage.

One of the big late-breaking trials presented at the 2026 American College of Cardiology (ACC) Scientific Sessions was the CHAMPION-AF, which showed left atrial appendage occlusion (LAAO) can offer a safe, non-drug alternative to anticoagulation therapy, even in patients with atrial fibrillation who are not at high risk for bleeding. First author of the study Shephal Doshi, MD, FACC, an electrophysiologist at Cedars Sinai Smidt Heart Institute, discussed the details of the trial. #LAAO #ACC #ACC26

New data point to LAAO as a safe alternative to long-term drug therapy

At the end of the day, one electrophysiologist explained, these decisions should still be made on a case-by-case basis.

Christoph Wald, MD, MBA, FACR, vice chair of the American College of Radiology (ACR) Board of Chancellors, professor of radiology and senior associate consultant for radiologist at Mayo Clinic, explains the ACR resources available to radiology practices to better evaluate artificial intelligence imaging algorithms.

American College of Radiology expands tools to help practices evaluate imaging AI

Incoming ACR board chair Christoph Wald, MD, explains the ACR resources available to radiology practices to better evaluate artificial intelligence imaging algorithms. 
 

Video interview with Society for Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, FACC, FAHA, MSCAI, explains the advancements in interventional cardiology the society has championed over the past year. #SCAI

Outgoing SCAI president reflects on a busy year full of partnerships and advocacy

SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months. 

Darryl Drevna, senior director of regulatory affairs, American Medical Group Association (AMGA), explains why the group objects to a near-complete freeze in an annual payment adjustment for Medicare Advantage (MA) plans, arguing it fails to keep pace with the real-world costs of delivering care to Medicare patients.

AMGA pushes back on Medicare Advantage payment adjustment and outlines needed reforms

The American Medical Group Association explains why it has issues with the payment adjustment for Medicare Advantage plans, arguing it fails to keep pace with the real-world costs.

Deepak Bhatt discusses the MOMENTUM STUDY and the prevalence of hypercortisolism hypertension. #ACC #ACC26

New data highlight an unexpected link between hypercortisolism and resistant hypertension

Clinicians may need to broaden their diagnostic approach when treating and managing patients with resistant hypertension. 

William P. Shutze, MD, FACS, secretary of the Society of Vascular Surgery (SVS), a vascular surgeon with Texas Vascular Associates in Plano, Texas, and a clinical associate professor of medicine at Texas A&M College of Medicine, explains the goals of the SVS quality assessment program.

SVS quality initiative gathers data to improve vascular care

More than 7,000 physicians from a wide variety of healthcare specialties are already participating in the project.

Video interview with Ronald Crystal, MD, chair, Department of Genetic Medicine at Weill Cornell Medicine, presented late-breaking findings on a first in-human, virus-delivered gene therapy trial to stop cardiomyopathy death in patients with Friedreich Ataxia (FA). #ACC #ACC26

New gene therapy may help protect the hearts of patients with Friedreich's ataxia

A majority of deaths from Friedreich's ataxia are associated with heart complications. A new treatment years in the making could provide some much-needed relief.